Schumann, S.
Scherthan, H.
Pfestroff, K.
Schoof, S.
Pfestroff, A.
Hartrampf, P.
Hasenauer, N.
Buck, A. K.
Luster, M.
Port, M.
Lassmann, M.
Eberlein, U.
Funding for this research was provided by:
h2020 euratom (755523)
Julius-Maximilians-Universität Würzburg
Article History
Received: 21 July 2021
Accepted: 26 October 2021
First Online: 13 November 2021
Declarations
:
: The common study protocol was presented to the local ethics committees at of the Medical Faculty of the University of Würzburg (UKW) and Marburg (UKM) and approved. All procedures performed in this study involving human participants were in accordance with the ethical standards of the respective ethics committees (UKW: Az. 246/18, UKM: Az. 83/19) and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: ML has received research grants by IPSEN Pharma and Nordic Nanovector. All other authors declare no competing interests.